Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 10 | 2021 | 1630 | 0.740 |
Why?
|
| Atrial Function, Left | 1 | 2020 | 153 | 0.730 |
Why?
|
| Shal Potassium Channels | 2 | 2013 | 22 | 0.580 |
Why?
|
| Heart Atria | 4 | 2020 | 1254 | 0.580 |
Why?
|
| Kv Channel-Interacting Proteins | 2 | 2013 | 57 | 0.560 |
Why?
|
| Adenine | 1 | 2020 | 897 | 0.550 |
Why?
|
| Purkinje Fibers | 1 | 2013 | 32 | 0.490 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2013 | 85 | 0.460 |
Why?
|
| Potassium Channel Blockers | 2 | 2013 | 172 | 0.440 |
Why?
|
| Piperidines | 1 | 2020 | 1582 | 0.440 |
Why?
|
| Potassium Channels | 2 | 2013 | 569 | 0.400 |
Why?
|
| Ventricular Fibrillation | 1 | 2013 | 534 | 0.380 |
Why?
|
| NFATC Transcription Factors | 4 | 2014 | 393 | 0.360 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 3 | 2021 | 178 | 0.360 |
Why?
|
| Heart Rate | 1 | 2020 | 4096 | 0.360 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2021 | 5412 | 0.350 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2008 | 99 | 0.340 |
Why?
|
| Phenethylamines | 1 | 2008 | 104 | 0.340 |
Why?
|
| Calcium Signaling | 2 | 2008 | 753 | 0.300 |
Why?
|
| Atrial Fibrillation | 4 | 2021 | 4562 | 0.300 |
Why?
|
| Tachycardia | 1 | 2008 | 603 | 0.290 |
Why?
|
| Calcium | 5 | 2021 | 5800 | 0.280 |
Why?
|
| Sulfonamides | 3 | 2018 | 1922 | 0.270 |
Why?
|
| Dogs | 6 | 2013 | 4045 | 0.250 |
Why?
|
| Barth Syndrome | 1 | 2021 | 26 | 0.210 |
Why?
|
| Cell Aggregation | 1 | 2021 | 255 | 0.210 |
Why?
|
| Leukemia, B-Cell | 1 | 2021 | 81 | 0.200 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 13626 | 0.200 |
Why?
|
| Mice, Inbred CBA | 1 | 2020 | 482 | 0.190 |
Why?
|
| Mice, 129 Strain | 1 | 2020 | 401 | 0.190 |
Why?
|
| Heart Conduction System | 3 | 2017 | 1029 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 4561 | 0.180 |
Why?
|
| Cell Nucleus | 1 | 2008 | 2995 | 0.180 |
Why?
|
| Indole Alkaloids | 1 | 2018 | 26 | 0.180 |
Why?
|
| Up-Regulation | 1 | 2008 | 4312 | 0.170 |
Why?
|
| Action Potentials | 5 | 2020 | 1780 | 0.170 |
Why?
|
| Aminoquinolines | 1 | 2018 | 107 | 0.170 |
Why?
|
| Myocardium | 2 | 2008 | 4909 | 0.170 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2018 | 438 | 0.160 |
Why?
|
| Coculture Techniques | 1 | 2021 | 1353 | 0.160 |
Why?
|
| Mitochondria, Heart | 1 | 2018 | 261 | 0.150 |
Why?
|
| Disulfides | 1 | 2018 | 462 | 0.150 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2021 | 2144 | 0.150 |
Why?
|
| Patch-Clamp Techniques | 3 | 2014 | 969 | 0.140 |
Why?
|
| Delayed Rectifier Potassium Channels | 1 | 2014 | 4 | 0.130 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 620 | 0.130 |
Why?
|
| Cells, Cultured | 7 | 2017 | 19905 | 0.130 |
Why?
|
| Calcineurin | 3 | 2014 | 227 | 0.130 |
Why?
|
| Heart Ventricles | 4 | 2013 | 3801 | 0.130 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2014 | 51 | 0.130 |
Why?
|
| Immediate-Early Proteins | 1 | 2017 | 457 | 0.130 |
Why?
|
| Isoproterenol | 1 | 2014 | 411 | 0.120 |
Why?
|
| Potassium | 4 | 2014 | 1329 | 0.120 |
Why?
|
| Tetraethylammonium | 1 | 2013 | 59 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 2099 | 0.120 |
Why?
|
| Databases, Genetic | 1 | 2020 | 1801 | 0.120 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2014 | 358 | 0.110 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2013 | 156 | 0.110 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2021 | 1592 | 0.110 |
Why?
|
| Ion Channel Gating | 1 | 2014 | 442 | 0.110 |
Why?
|
| Cricetulus | 1 | 2013 | 853 | 0.100 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2009 | 844 | 0.100 |
Why?
|
| Calcium Channels, L-Type | 2 | 2009 | 242 | 0.100 |
Why?
|
| CHO Cells | 1 | 2013 | 1437 | 0.100 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 572 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2018 | 3897 | 0.090 |
Why?
|
| Long QT Syndrome | 2 | 2015 | 421 | 0.090 |
Why?
|
| Cricetinae | 1 | 2013 | 2589 | 0.090 |
Why?
|
| Animals | 14 | 2021 | 169404 | 0.090 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2008 | 93 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 22663 | 0.080 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2008 | 164 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2021 | 15058 | 0.080 |
Why?
|
| Calcium Channel Blockers | 2 | 2008 | 698 | 0.080 |
Why?
|
| Torsades de Pointes | 1 | 2009 | 79 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1703 | 0.080 |
Why?
|
| Estradiol | 1 | 2015 | 1978 | 0.080 |
Why?
|
| Bradycardia | 1 | 2009 | 285 | 0.080 |
Why?
|
| Ion Transport | 1 | 2008 | 327 | 0.080 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2008 | 450 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2018 | 2968 | 0.080 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2008 | 234 | 0.070 |
Why?
|
| MicroRNAs | 2 | 2013 | 3637 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2021 | 11655 | 0.070 |
Why?
|
| Transfection | 1 | 2013 | 6089 | 0.060 |
Why?
|
| Ion Channels | 1 | 2008 | 1078 | 0.060 |
Why?
|
| Calcium-Binding Proteins | 1 | 2008 | 1090 | 0.060 |
Why?
|
| Sodium | 1 | 2008 | 1599 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 2008 | 1152 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 12305 | 0.050 |
Why?
|
| Macrophages | 1 | 2017 | 5742 | 0.050 |
Why?
|
| Genes, Wilms Tumor | 1 | 2021 | 79 | 0.050 |
Why?
|
| Retinal Dehydrogenase | 1 | 2021 | 73 | 0.050 |
Why?
|
| Egtazic Acid | 2 | 2014 | 182 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2021 | 162 | 0.050 |
Why?
|
| Semaphorins | 1 | 2021 | 117 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2013 | 3579 | 0.050 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2021 | 273 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 18197 | 0.050 |
Why?
|
| T-Box Domain Proteins | 1 | 2021 | 475 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 23476 | 0.040 |
Why?
|
| Mesoderm | 1 | 2021 | 723 | 0.040 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2021 | 652 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2021 | 717 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 3574 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2008 | 8657 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 484 | 0.040 |
Why?
|
| Connexin 43 | 1 | 2017 | 216 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2008 | 13212 | 0.040 |
Why?
|
| Humans | 12 | 2021 | 715818 | 0.040 |
Why?
|
| Clomiphene | 1 | 2015 | 71 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 14438 | 0.040 |
Why?
|
| Fertility Agents, Female | 1 | 2015 | 95 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1137 | 0.030 |
Why?
|
| Heart Failure | 2 | 2008 | 10041 | 0.030 |
Why?
|
| Benzoquinones | 1 | 2015 | 207 | 0.030 |
Why?
|
| Glycolysis | 1 | 2018 | 810 | 0.030 |
Why?
|
| Lactams, Macrocyclic | 1 | 2015 | 322 | 0.030 |
Why?
|
| Propanolamines | 1 | 2014 | 168 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 70879 | 0.030 |
Why?
|
| Second Messenger Systems | 1 | 2014 | 217 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2017 | 643 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2014 | 1421 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 2023 | 0.030 |
Why?
|
| Menstrual Cycle | 1 | 2015 | 533 | 0.030 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2015 | 512 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2014 | 1505 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 2824 | 0.020 |
Why?
|
| Infertility, Female | 1 | 2015 | 763 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2021 | 3279 | 0.020 |
Why?
|
| Protein Transport | 1 | 2015 | 2054 | 0.020 |
Why?
|
| Nimodipine | 1 | 2008 | 54 | 0.020 |
Why?
|
| Heterozygote | 1 | 2015 | 2794 | 0.020 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2014 | 841 | 0.020 |
Why?
|
| Calmodulin | 1 | 2008 | 214 | 0.020 |
Why?
|
| Stem Cells | 1 | 2021 | 3569 | 0.020 |
Why?
|
| Atrioventricular Block | 1 | 2009 | 110 | 0.020 |
Why?
|
| Imidazoles | 1 | 2014 | 1249 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2008 | 401 | 0.020 |
Why?
|
| Sodium Channels | 1 | 2008 | 359 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2013 | 7885 | 0.020 |
Why?
|
| Mice | 3 | 2021 | 80373 | 0.020 |
Why?
|
| Male | 5 | 2018 | 350352 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2015 | 2515 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 2008 | 529 | 0.020 |
Why?
|
| Zebrafish | 1 | 2017 | 3003 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 3066 | 0.020 |
Why?
|
| Tacrolimus | 1 | 2008 | 710 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 2985 | 0.020 |
Why?
|
| Female | 5 | 2017 | 377229 | 0.020 |
Why?
|
| Calcium Channels | 1 | 2008 | 652 | 0.020 |
Why?
|
| Binding Sites | 1 | 2013 | 6213 | 0.020 |
Why?
|
| Renin-Angiotensin System | 1 | 2008 | 763 | 0.020 |
Why?
|
| Cell Line | 1 | 2018 | 16575 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2009 | 1639 | 0.010 |
Why?
|
| Cell Death | 1 | 2008 | 1724 | 0.010 |
Why?
|
| Middle Aged | 2 | 2017 | 214666 | 0.010 |
Why?
|
| Rabbits | 1 | 2009 | 5060 | 0.010 |
Why?
|
| Adult | 2 | 2015 | 212279 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2015 | 6386 | 0.010 |
Why?
|
| Fibrosis | 1 | 2008 | 1928 | 0.010 |
Why?
|
| Hypertension | 1 | 2021 | 8270 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2008 | 1334 | 0.010 |
Why?
|
| Phenotype | 1 | 2018 | 16311 | 0.010 |
Why?
|
| Homeostasis | 1 | 2008 | 3332 | 0.010 |
Why?
|
| Rats | 1 | 2013 | 24852 | 0.010 |
Why?
|
| Time Factors | 2 | 2008 | 40887 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2018 | 23729 | 0.010 |
Why?
|
| Pregnancy | 1 | 2015 | 27398 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2015 | 51317 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 29290 | 0.010 |
Why?
|
| Prognosis | 1 | 2008 | 29007 | 0.010 |
Why?
|
Concepts
(172)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_